Open-Label Phase II Study of Neoadjuvant Bevacizumab Combined with FEC→Paclitaxel in Patients with Inflammatory or Locally Advanced Breast Cancer

被引：0
|
作者：
Venturini, M.
Del Mastro, L.
Aitini, E.
Saracchini, S.
Garrone, O.
Durando, A.
De Placido, S.
Boni, C.
Levaggi, A.
Scalamogna, R.
Galli, A.
Clavarezza, M.
机构：
[1] Osped Sacro Cuore Don Calabria, Negrar, VR, Italy
[2] Ist Nazl Ric Canc, Genoa, Italy
[3] Osped C Poma, Mantua, Italy
[4] Osped S Maria Angeli, Pordenone, Italy
[5] Osped Santa Croce & Carle, Cuneo, Italy
[6] Osped S Anna, Turin, Italy
[7] Univ Naples Federico II, Naples, Italy
[8] Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[9] Med Affairs, Monza, Italy
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P1-11-20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-11-20
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer
    Clavarezza, Matteo
    Turazza, Monica
    Aitini, Enrico
    Saracchini, Silvana
    Garrone, Ornella
    Durando, Antonio
    De Placido, Sabino
    Bisagni, Giancarlo
    Levaggi, Alessia
    Bighin, Claudia
    Restuccia, Eleonora
    Scalamogna, Roberto
    Galli, Anna
    Del Mastro, Lucia
    [J]. BREAST, 2013, 22 (04): : 470 - 475
  • [2] Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
    Velenik, Vaneja
    Ocvirk, Janja
    Music, Maja
    Bracko, Matej
    Anderluh, Franc
    Oblak, Irena
    Edhemovic, Ibrahim
    Brecelj, Erik
    Kropivnik, Mateja
    Omejc, Mirko
    [J]. RADIATION ONCOLOGY, 2011, 6
  • [3] Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
    Vaneja Velenik
    Janja Ocvirk
    Maja Music
    Matej Bracko
    Franc Anderluh
    Irena Oblak
    Ibrahim Edhemovic
    Erik Brecelj
    Mateja Kropivnik
    Mirko Omejc
    [J]. Radiation Oncology, 6
  • [4] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Denise A. Yardley
    E. Claire Dees
    Stephen D. Myers
    Sherry Li
    Paul Healey
    Zhixiao Wang
    Marla J. Brickman
    Jolanda Paolini
    Kenneth A. Kern
    Dennis L. Citrin
    [J]. Breast Cancer Research and Treatment, 2012, 136 : 759 - 767
  • [5] Phase II open-label study of sunitinib in patients with advanced breast cancer
    Yardley, Denise A.
    Dees, E. Claire
    Myers, Stephen D.
    Li, Sherry
    Healey, Paul
    Wang, Zhixiao
    Brickman, Marla J.
    Paolini, Jolanda
    Kern, Kenneth A.
    Citrin, Dennis L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 136 (03) : 759 - 767
  • [6] Phase II Study of Neoadjuvant S-1 Combined With Paclitaxel Followed by FEC in Patients With Breast Cancer
    Ikeda, T.
    Kamo, N.
    Shiga, C.
    Sasajima, Y.
    Imamura, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S379 - S379
  • [7] Neoadjuvant Chemotherapy with FEC and Paclitaxel ± Trastuzumab in locally Advanced Breast Cancer
    Mohr, K.
    Ruschke, K.
    Grosse, R.
    Strauss, H. G.
    Holzhausen, H. J.
    Spielmann, R. P.
    Hauptmann, S.
    Thomssen, C.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (08) : 752 - 752
  • [8] Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients
    Ezzat, AA
    Ibrahim, EM
    Ajarim, DS
    Rahall, MM
    Raja, MA
    Tulbah, AM
    Al-Malik, OA
    Al-Shabanah, M
    Sorbris, R
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (05) : 968 - 974
  • [9] Phase II study of neoadjuvant paclitaxel and cisplatin for operable and locally advanced breast cancer: analysis of 126 patients
    A A Ezzat
    E M Ibrahim
    D S Ajarim
    M M Rahal
    M A Raja
    A M Tulbah
    O A Al-Malik
    M Al-Shabanah
    R Sorbris
    [J]. British Journal of Cancer, 2004, 90 : 968 - 974
  • [10] A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
    Parton, Marina
    Bardia, Aditya
    Kummel, Sherko
    Estevez, Laura G.
    Huang, Chiun-Sheng
    Castan, Javier Cortes
    Borrego, Manuel Ruiz
    Telli, Melinda L.
    Lluch, Ana
    Lopez, Rafael
    Beck, J. Thaddeus
    Ismail-Khan, Roohi
    Chen, Shin-Cheh
    Hurvitz, Sara A.
    Mayer, Ingrid A.
    Atienza, Rolando S.
    Cameron, Scott
    Krygowski, Mizue
    Kim, Sung-Bae
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345